Insight into the binding model of per- and polyfluoroalkyl substances to proteins and membranes
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Legacy per- and polyfluoroalkyl substances (PFASs) have elicited much concern because of their ubiquitous distribution in the environment and the potential hazards they pose to wildlife and human health. Although an increasing number of effective PFAS alternatives are available in the market, these alternatives bring new challenges. This paper comprehensively reviews how PFASs bind to transport proteins (e.g., serum albumin, liver fatty acid transport proteins and organic acid transporters), nuclear receptors (e.g., peroxisome proliferator activated receptors, thyroid hormone receptors and reproductive hormone receptors) and membranes (e.g., cell membrane and mitochondrial membrane). Briefly, the hydrophobic fluorinated carbon chains of PFASs occupy the binding cavities of the target proteins, and the acid groups of PFASs form hydrogen bonds with amino acid residues. Various structural features of PFAS alternatives such as chlorine atom substitution, oxygen atom insertion and a branched structure, introduce variations in their chain length and hydrophobicity, which potentially change the affinity of PFAS alternatives for endogenous proteins. The toxic effects and mechanisms of action of legacy PFASs can be demonstrated and compared with their alternatives using binding models. In future studies, in vitro experiments and in silico quantitative structure-activity relationship modeling should be better integrated to allow more reliable toxicity predictions for both legacy and alternative PFASs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sunderland, E. M., Hu, X. C., Dassuncao, C., Tokranov, A. K., Wagner, C. C., & Allen, J. G. (2019) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/s41370-018-0094-1 · Cited by 2,786
Global Distribution of Perfluorooctane Sulfonate in Wildlife
Giesy, J. P., & Kannan, K. (2001) · Environmental Science & Technology · doi:10.1021/es001834k · Cited by 2,750
Olsen, G. W., Burris, J. M., Ehresman, D. J., Froehlich, J. W., Seacat, A. M., Butenhoff, J. L., & Zobel, L. R. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10009 · Cited by 2,049
Mechanisms of thyroid hormone action
Brent, G. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60047 · Cited by 1,244
Wang, Z., Cousins, I. T., Scheringer, M., & Hungerbühler, K. (2013) · Environment International · doi:10.1016/j.envint.2013.08.021 · Cited by 924
Accumulation of perfluoroalkyl substances in human tissues
Pérez, F., Nadal, M., Navarro-Ortega, A., Fàbrega, F., Domingo, J. L., Barceló, D., & Farré, M. (2013) · Environment International · doi:10.1016/j.envint.2013.06.004 · Cited by 730
Li, F., Duan, J., Tian, S., Ji, H., Zhu, Y., Wei, Z., & Zhao, D. (2020) · Chemical Engineering Journal · doi:10.1016/j.cej.2019.122506 · Cited by 707
Wang, S., Huang, J., Yang, Y., Hui, Y., Ge, Y., Larssen, T., Yu, G., Deng, S., Wang, B., & Harman, C. (2013) · Environmental Science & Technology · doi:10.1021/es401525n · Cited by 620
Subchronic Toxicity Studies on Perfluorooctanesulfonate Potassium Salt in Cynomolgus Monkeys
Seacat, A. M. (2002) · Toxicological Sciences · doi:10.1093/toxsci/68.1.249 · Cited by 564
Melzer, D., Rice, N., Depledge, M. H., Henley, W. E., & Galloway, T. S. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.0901584 · Cited by 496
Trends in the regulation of per- and polyfluoroalkyl substances (PFAS): a scoping review
Brennan, N. M., Evans, A. T., Fritz, M. K., Peak, S. A., & von Holst, H. E. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182010900 · Cited by 422
Perfluorinated acids as novel chemical tracers of global circulation of ocean waters
Yamashita, N., Taniyasu, S., Petrick, G., Wei, S., Gamo, T., Lam, P. K. S., & Kannan, K. (2008) · Chemosphere · doi:10.1016/j.chemosphere.2007.07.079 · Cited by 364
Shi, Y., Vestergren, R., Xu, L., Zhou, Z., Li, C., Liang, Y., & Cai, Y. (2016) · Environmental Science & Technology · doi:10.1021/acs.est.5b05849 · Cited by 357
Pan, Y., Zhang, H., Cui, Q., Sheng, N., Yeung, L. W. Y., Guo, Y., Sun, Y., & Dai, J. (2017) · Environmental Science & Technology · doi:10.1021/acs.est.7b02259 · Cited by 355
Perfluoroalkyl Acids and Related Chemistries—Toxicokinetics and Modes of Action
Andersen, M. E., Butenhoff, J. L., Chang, S.-C., Farrar, D. G., Kennedy, G. L., Lau, C., Olsen, G. W., Seed, J., & Wallace, K. B. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfm270 · Cited by 321
Sheng, N., Cui, R., Wang, J., Guo, Y., Wang, J., & Dai, J. (2018) · Archives of Toxicology · doi:10.1007/s00204-017-2055-1 · Cited by 295
Zhang, L., Ren, X.-M., & Guo, L.-H. (2013) · Environmental Science & Technology · doi:10.1021/es4026722 · Cited by 267
Lopez-Espinosa, M.-J., Fletcher, T., Armstrong, B., Genser, B., Dhatariya, K., Mondal, D., Ducatman, A., & Leonardi, G. (2011) · Environmental Science & Technology · doi:10.1021/es1038694 · Cited by 262
Shi, Y., Vestergren, R., Zhou, Z., Song, X., Xu, L., Liang, Y., & Cai, Y. (2015) · Environmental Science & Technology · doi:10.1021/acs.est.5b04299 · Cited by 258
Activation of Human Nuclear Receptors by Perfluoroalkylated Substances (PFAS)
Behr, A.-C., Plinsch, C., Braeuning, A., & Buhrke, T. (2020) · Toxicology in Vitro · doi:10.1016/j.tiv.2019.104700 · Cited by 235
Gao, K., Zhuang, T., Liu, X., Fu, J., Zhang, J., Fu, J., Wang, L., Zhang, A., Liang, Y., Song, M., et al. (2019) · Environmental Science & Technology · doi:10.1021/acs.est.9b00715 · Cited by 231
Beesoon, S., & Martin, J. W. (2015) · Environmental Science & Technology · doi:10.1021/es505399w · Cited by 223
Evans, N., Conley, J. M., Cardon, M., Hartig, P., Medlock-Kakaley, E., & Gray, L. E. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.116136 · Cited by 208
Thompson, J., Eaglesham, G., Reungoat, J., Poussade, Y., Bartkow, M., Lawrence, M., & Mueller, J. F. (2011) · Chemosphere · doi:10.1016/j.chemosphere.2010.10.040 · Cited by 198
Yang, C.-H., Glover, K. P., & Han, X. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq219 · Cited by 197
Meneguzzi, A., Fava, C., Castelli, M., & Minuz, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.706352 · Cited by 174
Goodrow, S. M., Ruppel, B., Lippincott, R. L., Post, G. B., & Procopio, N. A. (2020) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.138839 · Cited by 165
Cheng, W., & Ng, C. A. (2018) · Environmental Science & Technology · doi:10.1021/acs.est.8b01268 · Cited by 141
Bjork, J. A., & Wallace, K. B. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp093 · Cited by 137
Patlewicz, G., Richard, A. M., Williams, A. J., Grulke, C. M., Sams, R., Lambert, J., Noyes, P. D., DeVito, M. J., Hines, R. N., Strynar, M., et al. (2019) · Environmental Health Perspectives · doi:10.1289/ehp4555 · Cited by 128
Indoor exposure to per- and polyfluoroalkyl substances (PFAS) in the childcare environment
Zheng, G., Boor, B. E., Schreder, E., & Salamova, A. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2019.113714 · Cited by 112
PFAS and Potential Adverse Effects on Bone and Adipose Tissue through Interactions with PPARγ
Kirk, A. B., Michelsen-Correa, S., Rosen, C., Martin, C. F., & Blumberg, B. (2021) · Endocrinology · doi:10.1210/endocr/bqab194 · Cited by 90
Jackson, T. W., Scheibly, C. M., Polera, M. E., & Belcher, S. M. (2021) · Environmental Science & Technology · doi:10.1021/acs.est.1c01200 · Cited by 87
Covalent binding of perfluorinated fatty acids to proteins in the plasma, liver and testes of rats
Vanden Heuvel, J. P., Kuslikis, B. I., & Peterson, R. E. (1992) · Chemico-Biological Interactions · doi:10.1016/0009-2797(92)90003-4 · Cited by 84
Frigerio, G., Cafagna, S., Polledri, E., Mercadante, R., & Fustinoni, S. (2022) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-021-03762-1 · Cited by 80
Rand, A. A., & Mabury, S. A. (2013) · Environmental Science & Technology · doi:10.1021/es303760u · Cited by 34
Research works printed but not linked: 108
- Abbott, 2007, Perfluorooctanoic acid induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator activated receptor-alpha, Toxicol. Sci., 98, 571, 10.1093/toxsci/kfm110 · DOI · Paper page
- Alves, 2017, A biophysical approach to daunorubicin interaction with model membranes: relevance for the drug's biological activity, J. R. Soc. Interface, 14, 20170408, 10.1098/rsif.2017.0408 · DOI
- Atshaves, 2010, Liver fatty acid-binding protein and obesity, J. Nutr. Biochem., 21, 1015, 10.1016/j.jnutbio.2010.01.005 · DOI · Paper page
- Banjabi, 2020, Serum concentrations of perfluoroalkyl substances and their association with osteoporosis in a population in Jeddah, Saudi Arabia. Environmental Research, 187
- Becanova, 2016, Screening for perfluoroalkyl acids in consumer products, building materials and wastes, Chemosphere, 164, 322, 10.1016/j.chemosphere.2016.08.112 · DOI · Paper page
- Benninghoff, 2011, Estrogen-like activity of perfluoroalkyl acids in vivo and interaction with human and rainbow trout estrogen receptors in vitro, Toxicol. Sci., 120, 42, 10.1093/toxsci/kfq379 · DOI · Paper page
- Berger, 2002, Physiological and therapeutic roles of peroxisome proliferator-activated receptors, Diabetes Technol. Ther., 4, 163, 10.1089/15209150260007381 · DOI · Paper page
- Bjork, 2011, Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes, Toxicology, 288, 8, 10.1016/j.tox.2011.06.012 · DOI · Paper page
- Camdzic, 2022, Cellular Interactions and Fatty Acid Transporter CD36-Mediated Uptake of Per- and Polyfluorinated Alkyl Substances (PFAS), Chem. Res. Toxicol., 694, 10.1021/acs.chemrestox.2c00078 · DOI
- Cao, 2019, Screening of Potential PFOS Alternatives To Decrease Liver Bioaccumulation: Experimental and Computational Approaches, Environ. Sci. Tech., 53, 2811, 10.1021/acs.est.8b05564 · DOI · Paper page
- Cao, 2022, Effect of Enterohepatic Circulation on the Accumulation of Per- and Polyfluoroalkyl Substances: Evidence from Experimental and Computational Studies, Environ. Sci. Tech., 56, 3214, 10.1021/acs.est.1c07176 · DOI · Paper page
- Cha, 2000, Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta, J. Biol. Chem., 275, 4507, 10.1074/jbc.275.6.4507 · DOI · Paper page
- Chang, 2008, Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS), Toxicology, 243, 330, 10.1016/j.tox.2007.10.014 · DOI · Paper page
- Chávez-Galán, 2009, Cell Death Mechanisms Induced by Cytotoxic Lymphocytes, Cell. Mol. Immunol., 6, 15, 10.1038/cmi.2009.3 · DOI · Paper page
- Chen, 2001, Role of mitochondrial dysfunction in S-(1,2-dichlorovinyl)-l-cysteine-induced apoptosis, Toxicol. Appl. Pharmacol., 170, 172, 10.1006/taap.2000.9107 · DOI
- Cheng, 2017, A permeability-limited physiologically based pharmacokinetic (PBPK) model for perfluorooctanoic acid (PFOA) in male rats, Environ. Sci. Tech., 51, 9930, 10.1021/acs.est.7b02602 · DOI · Paper page
- Cheng, 2019, Using Machine Learning to Classify Bioactivity for 3486 Per- and Polyfluoroalkyl Substances (PFASs) from the OECD List, Environ. Sci. Tech., 53, 13970, 10.1021/acs.est.9b04833 · DOI · Paper page
- Choi, 2014, Revisiting PPARgamma as a target for the treatment of metabolic disorders, BMB Rep., 47, 599, 10.5483/BMBRep.2014.47.11.174 · DOI
- Coperchini, 2020, Thyroid disrupting effects of old and new generation PFAS, Front Endocrinol (Lausanne), 11
- Cui, 2020, Exposure to per- and polyfluoroalkyl substances (PFASs) in serum versus semen and their association with male reproductive hormones, Environ. Pollut., 266, 10.1016/j.envpol.2020.115330 · DOI
- Daems, 2021, Native mass spectrometry for the design and selection of protein bioreceptors for perfluorinated compounds, Analyst, 146, 2065, 10.1039/D0AN02005B · DOI
- De Toni, 2020, Increased cardiovascular risk associated with chemical sensitivity to perfluoro–octanoic acid: role of impaired platelet aggregation, Int. J. Mol. Sci., 21, 399, 10.3390/ijms21020399 · DOI · Paper page
- Delva-Wiley, 2021, Computational Analysis of the Binding Mechanism of GenX and HSA, ACS Omega, 6, 29166, 10.1021/acsomega.1c04592 · DOI
- Deng, 2018, Multiple approaches to assess the effects of F-53B, a Chinese PFOS alternative, on thyroid endocrine disruption at environmentally relevant concentrations, Sci. Total Environ., 624, 215, 10.1016/j.scitotenv.2017.12.101 · DOI
- Duan, 2021, Perfluorooctane sulfonate continual exposure impairs glucose-stimulated insulin secretion via SIRT1-induced upregulation of UCP2 expression, Environ. Pollut., 278, 10.1016/j.envpol.2021.116840 · DOI
- Dunder, 2022, Changes in plasma levels of per- and polyfluoroalkyl substances (PFAS) are associated with changes in plasma lipids - A longitudinal study over 10 years, Environ. Res., 211, 10.1016/j.envres.2022.112903 · DOI · Paper page
- Endo, 2022, Applicability Domain of Polyparameter Linear Free Energy Relationship Models Evaluated by Leverage and Prediction Interval Calculation, Environ. Sci. Tech., 56, 5572, 10.1021/acs.est.2c00865 · DOI · Paper page
- Fedorenko, 2021, Dominant entropic binding of perfluoroalkyl substances (PFASs) to albumin protein revealed by (19)F NMR, Chemosphere, 263, 10.1016/j.chemosphere.2020.128083 · DOI · Paper page
- Forsthuber, 2020, Albumin is the major carrier protein for PFOS, PFOA, PFHxS, PFNA and PFDA in human plasma, Environ. Int., 137, 10.1016/j.envint.2019.105324 · DOI · Paper page
- Furuhashi, 2008, Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets, Nat. Rev. Drug Discov., 7, 489, 10.1038/nrd2589 · DOI · Paper page
- Gallo, 2012, Serum perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) concentrations and liver function biomarkers in a population with elevated PFOA exposure, Environ. Health Perspect., 120, 655, 10.1289/ehp.1104436 · DOI · Paper page
- Gao, 2013, Assessment of estrogenic activity of perfluoroalkyl acids based on ligand-induced conformation state of human estrogen receptor, Environ. Sci. Tech., 47, 634, 10.1021/es304030x · DOI · Paper page
- Gao, 2015, Differential accumulation and elimination behavior of perfluoroalkyl Acid isomers in occupational workers in a manufactory in China, Environ. Sci. Tech., 49, 6953, 10.1021/acs.est.5b00778 · DOI · Paper page
- Golius, 2016, Experimental and computational study of membrane affinity for selected energetic compounds, Chemosphere, 148, 322, 10.1016/j.chemosphere.2016.01.010 · DOI
- Gordon, 2011, Toxicological evaluation of ammonium 4,8-dioxa-3H-perfluorononanoate, a new emulsifier to replace ammonium perfluorooctanoate in fluoropolymer manufacturing, Regul. Toxicol. Pharm., 59, 64, 10.1016/j.yrtph.2010.09.008 · DOI
- Han, 2003, Binding of Perfluorooctanoic Acid to Rat and Human Plasma Proteins, Chem. Res. Toxicol., 16, 775, 10.1021/tx034005w · DOI · Paper page
- Henley, 2009, The short-chain fatty acid methoxyacetic acid disrupts endogenous estrogen receptor-alpha-mediated signaling, Environ. Health Perspect., 117, 1702, 10.1289/ehp.0900800 · DOI
- Hernandez, 2022, Proteins as adsorbents for PFAS removal from water, Environ. Sci. Water Res. Technol., 8, 1188, 10.1039/D1EW00501D · DOI
- Houck, 2021, Bioactivity profiling of per- and polyfluoroalkyl substances (PFAS) identifies potential toxicity pathways related to molecular structure, Toxicology, 457, 10.1016/j.tox.2021.152789 · DOI · Paper page
- Hu, 2003, Alterations in cell membrane properties caused by perfluorinated compounds, Comp. Biochem. Physiol. C: Toxicol. Pharmacol., 135, 77
- Hu, 2002, Inhibition of gap junctional intercellular communication by perfluorinated compounds in rat liver and dolphin kidney epithelial cell lines in vitro and Sprague-Dawley rats in vivo, Toxicol. Sci., 68, 429, 10.1093/toxsci/68.2.429 · DOI · Paper page
- Huang, 2021, Developmental toxicity of the novel PFOS alternative OBS in developing zebrafish: An emphasis on cilia disruption, J. Hazard. Mater., 409, 10.1016/j.jhazmat.2020.124491 · DOI
- Jane, 2022, Health-related toxicity of emerging per- and polyfluoroalkyl substances: Comparison to legacy PFOS and PFOA, Environ. Res., 212
- Jones, 2003, Binding of perfluorinated fatty acids to serum proteins, Environ. Toxicol. Chem., 22, 2639, 10.1897/02-553 · DOI · Paper page
- Kar, 2017, Endocrine-disrupting activity of per- and polyfluoroalkyl substances: Exploring combined approaches of ligand and structure based modeling, Chemosphere, 184, 514, 10.1016/j.chemosphere.2017.06.024 · DOI
- Khazaee, 2021, Perfluoroalkyl acid binding with peroxisome proliferator-activated receptors α, γ, and δ, and fatty acid binding proteins by equilibrium dialysis with a comparison of methods, Toxics, 9, 45, 10.3390/toxics9030045 · DOI · Paper page
- Kjeldsen, 2013, Perfluorinated compounds affect the function of sex hormone receptors, Environ. Sci. Pollut. Res., 20, 8031, 10.1007/s11356-013-1753-3 · DOI · Paper page
- Kleszczynski, 2009, Mechanism of cytotoxic action of perfluorinated acids. I. alteration in plasma membrane potential and intracellular pH level, Toxicol. Appl. Pharmacol., 234, 300, 10.1016/j.taap.2008.10.008 · DOI
- Kleszczynski, 2011, Mechanism of cytotoxic action of perfluorinated acids. III. Disturbance in Ca(2)+ homeostasis, Toxicol. Appl. Pharmacol., 251, 163, 10.1016/j.taap.2011.01.002 · DOI
- Kleszczynski, 2009, Mechanism of cytotoxic action of perfluorinated acids II. Disruption of mitochondrial bioenergetics, Toxicol. Appl. Pharmacol., 235, 182, 10.1016/j.taap.2008.11.021 · DOI
- Koupenova, 2018, Biology of platelet purinergic receptors and implications for platelet heterogeneity, Front Pharmacology, 9, 37, 10.3389/fphar.2018.00037 · DOI
- Kummu, 2015, Organic anion transporter 4 (OAT 4) modifies placental transfer of perfluorinated alkyl acids PFOS and PFOA in human placental ex vivo perfusion system, Placenta, 36, 1185, 10.1016/j.placenta.2015.07.119 · DOI
- Li, 2020, Evaluation of the Estrogenic/Antiestrogenic Activities of Perfluoroalkyl Substances and Their Interactions with the Human Estrogen Receptor by Combining In Vitro Assays and In Silico Modeling, Environ. Sci. Tech., 54, 14514, 10.1021/acs.est.0c03468 · DOI
- Li, 2018, Perfluorooctane sulfonate impairs rat Leydig cell development during puberty, Chemosphere, 190, 43, 10.1016/j.chemosphere.2017.09.116 · DOI
- Li, 2019, Investigation of binding and activity of perfluoroalkyl substances to the human peroxisome proliferator-activated receptor beta/delta, Environ. Sci. Processes Impacts, 21, 1908, 10.1039/C9EM00218A · DOI · Paper page
- Li, 2019, Adipogenic activity of oligomeric hexafluoropropylene oxide (perfluorooctanoic acid alternative) through peroxisome proliferator-activated receptor γ pathway, Environ. Sci. Tech., 53, 3287, 10.1021/acs.est.8b06978 · DOI · Paper page
- Liu, 2018, Bioaccumulation and effects of novel chlorinated polyfluorinated ether sulfonate in freshwater alga Scenedesmus obliquus, Environ. Pollut., 233, 8, 10.1016/j.envpol.2017.10.039 · DOI
- Liu, 2021, Prenatal and postnatal transfer of perfluoroalkyl substances from mothers to their offspring, Crit. Rev. Environ. Sci. Technol., 1
- Liu, 2021, Associations between six common per- and polyfluoroalkyl substances and estrogens in neonates of China, J. Hazard. Mater., 407, 10.1016/j.jhazmat.2020.124378 · DOI · Paper page
- Lu, 2021, The occurrence of PFAS in human placenta and their binding abilities to human serum albumin and organic anion transporter 4, Environ. Pollut., 273, 10.1016/j.envpol.2021.116460 · DOI · Paper page
- Luo, 2012, Structural evidence of perfluorooctane sulfonate transport by human serum albumin, Chem. Res. Toxicol., 25, 990, 10.1021/tx300112p · DOI · Paper page
- Lv, 2021, The molecular-level understanding of the uptake of PFOS and its alternatives (6:2 Cl-PFESA and OBS) into phospholipid bilayers, J. Hazard. Mater., 417, 10.1016/j.jhazmat.2021.125991 · DOI
- Mann, 2022, Engineering human liver fatty acid binding protein for detection of poly- and perfluoroalkyl substances, Biotechnol Bioeng, 119, 513, 10.1002/bit.27981 · DOI
- Martin, 2007, Toxicogenomic Study of Triazole Fungicides and Perfluoroalkyl Acids in Rat Livers Predicts Toxicity and Categorizes Chemicals Based on Mechanisms of Toxicity, Toxicol. Sci., 97, 595, 10.1093/toxsci/kfm065 · DOI · Paper page
- Maso, 2021, Unveiling the binding mode of perfluorooctanoic acid to human serum albumin, Protein Sci., 30, 830, 10.1002/pro.4036 · DOI
- Moller, 1982, Renal organic anion transport system: pharmacological physiological, and biochemical aspects, Pharmacol. Rev., 34, 315, 10.1016/S0031-6997(25)00055-9 · doi:10.1016/s0031-6997(25)00055-9
- Mortensen, 2020, Homology modeling to screen for potential binding of contaminants to thyroid hormone receptor and transthyretin in glaucous gull (Larus hyperboreus) and herring gull (Larus argentatus), Comput. Toxicol., 13, 10.1016/j.comtox.2020.100120 · DOI
- Nakagawa, 2008, Roles of organic anion transporters in the renal excretion of perfluorooctanoic acid, Basic Clin. Paharmacol. Toxicol., 103, 1, 10.1111/j.1742-7843.2007.00155.x · DOI · Paper page
- Ng, 2015, Exploring the Use of Molecular Docking to Identify Bioaccumulative Perfluorinated Alkyl Acids (PFAAs), Environ. Sci. Tech., 49, 12306, 10.1021/acs.est.5b03000 · DOI · Paper page
- Nielsen, 2022, Predicting the effects of per-and polyfluoroalkyl substance mixtures on peroxisome proliferator-activated receptor alpha activity in vitro, Toxicology, 153024
- Nolte, 1998, Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-g, Nature, 395, 137, 10.1038/25931 · DOI · Paper page
- Olsen, 2017, Per- and polyfluoroalkyl substances (PFAS) in American Red Cross adult blood donors, 2000–2015, Environ. Res., 157, 87, 10.1016/j.envres.2017.05.013 · DOI · Paper page
- Palioura, 2022, PPARβ/δ at the crossroads of energy metabolism, mitochondrial quality control and redox balance, Journal of Biological Research - Thessaloniki, 29
- Qu, 2018, Perfluorinated compounds binding to estrogen receptor of different species: a molecular dynamic modeling, J. Mol. Model., 25, 1, 10.1007/s00894-018-3878-2 · DOI
- Ren, 2015, Structure-activity relations in binding of perfluoroalkyl compounds to human thyroid hormone T3 receptor, Arch. Toxicol., 89, 233, 10.1007/s00204-014-1258-y · DOI · Paper page
- Ren, 2016, Binding interactions of perfluoroalkyl substances with thyroid hormone transport proteins and potential toxicological implications, Toxicology, 366–367, 32, 10.1016/j.tox.2016.08.011 · DOI · Paper page
- Richieri, 2000, Fatty acid binding proteins from different tissues show distinct patterns of fatty acid interactions, Biochemistry, 39, 7197, 10.1021/bi000314z · DOI · Paper page
- Rodowa, 2020, Field Sampling Materials Unlikely Source of Contamination for Perfluoroalkyl and Polyfluoroalkyl Substances in Field Samples, Environ. Sci. Technol. Lett., 7, 156, 10.1021/acs.estlett.0c00036 · DOI · Paper page
- Schroeder, 2001, Expression of liver fatty acid binding protein alters growth and differentiation of embryonic stem cells, Mol. Cell. Biochem., 219, 127, 10.1023/A:1010851130136 · DOI
- Schultza, 2003, Definitely quantitative structure-activity relationship (QSAR) models together with molecular simulation methods were permitted to predict health adverse impacts, J. Mol. Struct. (Thoechem), 622, 1
- Shen, 2020, Cholesterol-like condensing effect of perfluoroalkyl substances on a phospholipid bilayer, J. Phys. Chem. B, 124, 5415, 10.1021/acs.jpcb.0c00980 · DOI
- Sheng, 2016, Interaction of perfluoroalkyl acids with human liver fatty acid-binding protein, Arch Toxicol, 90, 217, 10.1007/s00204-014-1391-7 · DOI · Paper page
- Sheng, 2020, Interactions of perfluorooctanesulfonate and 6: 2 chlorinated polyfluorinated ether sulfonate with human serum albumin: a comparative study, Chem. Res. Toxicol., 33, 1478, 10.1021/acs.chemrestox.0c00075 · DOI
- Shi, 2012, Tissue distribution of perfluorinated compounds in farmed freshwater fish and human exposure by consumption, Environ. Toxicol. Chem., 31, 717, 10.1002/etc.1758 · DOI · Paper page
- Shoeib, 2016, Poly- and perfluoroalkyl substances (PFASs) in indoor dust and food packaging materials in Egypt: Trends in developed and developing countries, Chemosphere, 144, 1573, 10.1016/j.chemosphere.2015.08.066 · DOI
- Soderstrom, 2022, Agonistic and potentiating effects of perfluoroalkyl substances (PFAS) on the Atlantic cod (Gadus morhua) peroxisome proliferator-activated receptors (Ppars), Environ. Int., 163, 10.1016/j.envint.2022.107203 · DOI
- Steenland, 2021, PFAS and cancer, a scoping review of the epidemiologic evidence, Environ. Res., 194, 10.1016/j.envres.2020.110690 · DOI · Paper page
- Suresh Babu, 2022, Experimental insights into anodic oxidation of hexafluoropropylene oxide dimer acid (GenX) on boron-doped diamond anodes, Chemosphere, 288, 10.1016/j.chemosphere.2021.132417 · DOI
- Tu, 2019, Bioconcentration and metabolic effects of emerging PFOS alternatives in developing zebrafish, Environ. Sci. Tech., 53, 13427, 10.1021/acs.est.9b03820 · DOI
- Ugele, 2003, Characterization and identification of steroid sulfatetransporters of human placenta, American Journal of Physiology-Endocrinology and Metabolism, 284, E390, 10.1152/ajpendo.00257.2002 · DOI · Paper page
- Wang, 2019, PFOS, PFOA, estrogen homeostasis, and birth size in Chinese infants, Chemosphere, 221, 349, 10.1016/j.chemosphere.2019.01.061 · DOI · Paper page
- Wang, 2017, Serum metabolome biomarkers associate low-level environmental perfluorinated compound exposure with oxidative /nitrosative stress in humans, Environ. Pollut., 229, 168, 10.1016/j.envpol.2017.04.086 · DOI
- Weaver, 2010, Roles of rat renal organic anion transporters in transporting perfluorinated carboxylates with different chain lengths, Toxicol. Sci., 113, 305, 10.1093/toxsci/kfp275 · DOI · Paper page
- Weiss, 2009, Competitive binding of poly- and perfluorinated compounds to the thyroid hormone transport protein transthyretin, Toxicol. Sci., 109, 206, 10.1093/toxsci/kfp055 · DOI · Paper page
- Wen, 2015, Unliganded thyroid hormone receptor alpha controls developmental timing in Xenopus tropicalis, Endocrinology, 156, 721, 10.1210/en.2014-1439 · DOI
- Wolf, 2008, Activation of mouse and human peroxisome proliferator-activated receptor alpha by perfluoroalkyl acids of different functional groups and chain lengths, Toxicol. Sci., 106, 162, 10.1093/toxsci/kfn166 · DOI · Paper page
- Wu, 2017, Analysis of perfluorinated compounds in human serum from the general population in Shanghai by liquid chromatography-tandem mass spectrometry (LC-MS/MS), Chemosphere, 168, 100, 10.1016/j.chemosphere.2016.09.161 · DOI
- Wu, 2022, Global performance and trends of research on per- and polyfluoroalkyl substances (PFASs) between 2001 and 2018 using bibliometric analysis, Chemosphere, 295, 10.1016/j.chemosphere.2022.133853 · DOI
- Xiao, 2017, An important intestinal transporter that regulates the enterohepatic circulation of bile acids and cholesterol homeostasis: The apical sodium-dependent bile acid transporter (SLC10A2/ASBT), Clin. Res. Hepatol. Gastroenterol., 41, 509, 10.1016/j.clinre.2017.02.001 · DOI
- Xin, 2019, Comparative in vitro and in vivo evaluation of the estrogenic effect of hexafluoropropylene oxide homologues, Environ. Sci. Tech., 53, 8371, 10.1021/acs.est.9b01579 · DOI · Paper page
- Yang, 2020, Nontarget screening of per-and polyfluoroalkyl substances binding to human liver fatty acid binding protein, Environ. Sci. Tech., 54, 5676, 10.1021/acs.est.0c00049 · DOI · Paper page
- Yao, 2023, Emerging and Legacy Perfluoroalkyl Substances in Breastfed Chinese Infants: Renal Clearance, Body Burden, and Implications, Environ. Health Perspect., 131, 37003, 10.1289/EHP11403 · DOI
- Yee, 2021, Emerging Roles of the Human Solute Carrier 22 Family, Drug Metab. Dispos., 50, 1193, 10.1124/dmd.121.000702 · DOI · Paper page
- Yi, 2019, Probing the hepatotoxicity mechanisms of novel chlorinated polyfluoroalkyl sulfonates to zebrafish larvae: Implication of structural specificity, Environ. Int., 133, 10.1016/j.envint.2019.105262 · DOI
- Young, 2021, Assessing Indoor Dust Interference with Human Nuclear Hormone Receptors in Cell-Based Luciferase Reporter Assays, Environ. Health Perspect., 129, 47010, 10.1289/EHP8054 · DOI
- Zhang, 2021, Varied thyroid disrupting effects of perfluorooctanoic acid (PFOA) and its novel alternatives hexafluoropropylene-oxide-dimer-acid (GenX) and ammonium 4,8-dioxa-3H-perfluorononanoate (ADONA) in vitro, Environ. Int., 156, 10.1016/j.envint.2021.106745 · DOI · Paper page
- Zhao, 2014, Concentration-dependent polyparameter linear free energy relationships to predict organic compound sorption on carbon nanotubes, Sci. Rep., 4, 3888, 10.1038/srep03888 · doi:10.1038/srep03888
- Zoete, 2007, Peroxisome proliferator-activated receptor structures: ligand specificity, molecular switch and interactions with regulators. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of, Lipids, 1771, 915
Cited by
Rosato, I., Bonato, T., Fletcher, T., Batzella, E., & Canova, C. (2024) · Environmental Research · doi:10.1016/j.envres.2023.117743 · Cited by 273
Strong bioaccumulation of a wide variety of PFAS in a contaminated terrestrial and aquatic ecosystem
Gkika, I. S., Arie Vonk, J., ter Laak, T. L., van Gestel, C. A. M., Dijkstra, J., Groffen, T., Bervoets, L., & Kraak, M. H. S. (2025) · Environment International · doi:10.1016/j.envint.2025.109629 · Cited by 38
Liu, Y., Zhang, H., Xu, F., Zhang, X., Zhao, N., & Ding, L. (2024) · Science of The Total Environment · doi:10.1016/j.scitotenv.2024.171305 · Cited by 24
Predicting Salt Effects on the Binding of PFAS to Protein
Gao, Y., Kibbey, T. C. G., Lee, M. J., & O’Carroll, D. M. (2025) · Environmental Science & Technology · doi:10.1021/acs.est.5c08779 · Cited by 5
Metadata
- Authors
- Zhao, L., Teng, M., Zhao, X., Li, Y., Sun, J., Zhao, W., Ruan, Y., Leung, K. M. Y., & Wu, F.
- Venue
- Environment International
- Publisher
- Elsevier BV
- Published
- 2023-05
- Volume
- 175
- Pages
- 107951
- ISSN
- 0160-4120 (ISSN-L)
- OpenAlex
- W4367322125
- Cited by
- 218
- References
- 36
- FWCI
- 17.88
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- State Key Laboratory in Marine Pollution
- National Natural Science Foundation of China (42207335)
- Ministry of Science and Technology of the People's Republic of China
- Innovation and Technology Commission (PJ9448002)
- China Academy of Space Technology
- China Association for Science and Technology (2022QNRC001)
- National Key Research and Development Program of China (2021YFC3201000)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.